| ATC codes |
|---|
| M Musculo-skeletal system |
| M01 Anti-inflammatory and antirheumatic products |
| M02 Topical products for joint and muscular pain |
| M03 Muscle relaxants |
| M04 Antigout preparations |
| M05 Drugs for treatment of bone diseases |
| M09 Other drugs for disorders of the musculo-skeletal system |
|
|
ATC code M05 Drugs for treatment of bone diseases is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup M05 is part of the anatomical group M Musculo-skeletal system.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QM05...[2]
Contents |
M05B Drugs affecting bone structure and mineralization
M05BA Bisphosphonates
- M05BA01 Etidronic acid
- M05BA02 Clodronic acid
- M05BA03 Pamidronic acid
- M05BA04 Alendronic acid
- M05BA05 Tiludronic acid
- M05BA06 Ibandronic acid
- M05BA07 Risedronic acid
- M05BA08 Zoledronic acid
M05BB Bisphosphonates, combinations
- M05BB01 Etidronic acid and calcium, sequential
- M05BB02 Risedronic acid and calcium, sequential
- M05BB03 Alendronic acid and colecalciferol
- M05BB04 Risedronic acid, calcium and colecalciferol, sequential
M05BC Bone morphogenetic proteins
- M05BC01 Dibotermin alfa
- M05BC02 Eptotermin alfa
M05BX Other drugs affecting bone structure and mineralization
- M05BX01 Ipriflavone
- M05BX02 Aluminium chlorohydrate
- M05BX03 Strontium ranelate
- M05BX04 Denosumab
References
- ^ "ATC Index". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atc_ddd_index/.
- ^ "ATCvet Index". WHO Collaborating Centre for Drug Statistics Methodology. http://www.whocc.no/atcvet/atcvet_index/.
|
|||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
